Table 5: BMI comparison: Drug User
Cohort to NHIS Data. (N=151).
|
BMI Classification |
||||||||||||||||||||
Underweight |
Normal Weight |
Overweight |
Obese |
||||||||||||||||||
Cohort |
NHIS |
Cohort |
NHIS |
Cohort |
NHIS |
Cohort |
NHIS |
||||||||||||||
Obs (% of 151) |
Exp |
Obs/Exp |
p-value |
95% CI |
Obs (% of 151) |
Exp |
Obs/Exp |
p-value |
95% CI |
Obs (% of 151) |
Exp |
Obs/Exp |
p-value |
95% CI |
Obs (% of 151) |
Exp |
Obs/Exp |
p-value |
95% CI |
|
|
Overall |
7 (4.6) |
1.76 |
3.98 |
0.005** |
1.60-8.19 |
40 (26.5) |
40.2 |
1.00 |
0.936 |
0.71-1.36 |
40 (26.5) |
50.8 |
0.79 |
0.141 |
0.56-1.07 |
64 (42.4) |
58.3 |
1.01 |
0.488 |
0.85-1.40 |
|
Hispanic |
1 (0.7) |
0.18 |
5.52 |
0.332 |
0.14-30.73 |
7 (4.6) |
7.66 |
0.91 |
0.997 |
0.37-1.88 |
9 (6.0) |
13.7 |
0.66 |
0.246 |
0.30-1.24 |
17 (11.3) |
12.4 |
1.37 |
0.253 |
0.80-2.19 |
|
Black NH |
4 (2.6) |
0.54 |
7.36 |
0.005** |
2.00-18.83 |
14 (9.3) |
12.0 |
1.17 |
0.633 |
0.64-1.96 |
14 (9.3) |
19.1 |
0.73 |
0.287 |
0.40-1.23 |
27 (17.9) |
27.4 |
0.99 |
0.952 |
0.65-1.44 |
|
White NH |
2 (1.3) |
0.91 |
2.21 |
0.459 |
0.27-7.98 |
19 (12.6) |
19.0 |
1.00 |
0.883 |
0.60-1.56 |
15 (9.9) |
17.2 |
0.87 |
0.708 |
0.49-1.44 |
19 (12.6) |
17.9 |
1.06 |
0.853 |
0.64-1.66 |
|
Male |
3 (2.0) |
0.39 |
7.69 |
0.015* |
1.59-22.48 |
16 (10.6) |
14.1 |
1.13 |
0.685 |
0.65-1.84 |
22 (14.6) |
26.2 |
0.84 |
0.477 |
0.53-1.27 |
21 (13.9) |
21.3 |
0.99 |
0.931 |
0.61-1.51 |
|
Female |
4 (2.6) |
1.37 |
2.92 |
0.101 |
0.80-7.48 |
24 (15.9) |
26.0
|
0.92 |
0.786 |
0.59-1.37 |
18 (11.9) |
24.6 |
0.73 |
0.213 |
0.43-1.16 |
43 (28.5) |
37.0 |
1.16 |
0.365 |
0.84-1.57 |
|
21-35 |
1 (0.7) |
0.52 |
1.91 |
0.814 |
0.05-10.66 |
9 (6.0) |
9.49 |
0.95 |
0.955 |
0.43-1.80 |
4 (2.6) |
6.34 |
0.63 |
0.484 |
0.17-1.62 |
9 (6.0) |
6.64 |
1.35 |
0.452 |
0.62-2.57 |
|
36-40 |
1 (0.7) |
0.15 |
6.65 |
0.279 |
0.17-37.07 |
4 (2.6) |
4.69 |
0.85 |
1.000 |
0.23-2.19 |
5 (3.3) |
6.90 |
0.72 |
0.627 |
0.24-1.69 |
8 (5.3) |
6.26 |
1.28 |
0.586 |
0.55-2.52 |
|
41-45 |
1 (0.7) |
0.13 |
7.78 |
0.241 |
0.20-43.33 |
4 (2.6) |
3.39 |
1.18 |
0.878 |
0.32-3.02 |
2 (1.3) |
4.01 |
0.50 |
0.472 |
0.06-1.80 |
5 (3.3) |
4.47 |
1.12 |
0.924 |
0.36-2.61 |
|
46-50 |
N.C. |
N.C. |
N.C. |
N.C. |
N.C. |
2 (1.3) |
4.30 |
0.47 |
0.396 |
0.06-1.68 |
5 (3.3) |
7.12 |
0.70 |
0.571 |
0.23-1.64 |
14 (9.3) |
9.44 |
1.48 |
0.197 |
0.81-2.49 |
|
51-55 |
1 (0.7) |
0.19 |
5.20 |
0.350 |
0.13-28.97 |
8 (5.3) |
5.85 |
1.37 |
0.470 |
0.59-2.70 |
6 (4.0) |
8.56
|
0.70 |
0.499 |
0.26-1.53 |
11 (7.3) |
11.4
|
0.97 |
0.936 |
0.48-1.73 |
|
56-60 |
1 (0.7) |
0.25 |
4.06 |
0.436 |
0.10-22.64 |
7 (4.6) |
5.72 |
1.23 |
0.696 |
0.49-2.52 |
7 (4.6) |
8.74 |
0.80 |
0.710 |
0.32-1.65 |
11 (7.3) |
11.3 |
0.97 |
0.912 |
0.49-1.74 |
|
61-65 |
N.C. |
N.C. |
N.C. |
N.C. |
N.C. |
4 (2.6) |
4.34 |
0.92 |
0.874 |
0.25-2.36 |
7 (4.6) |
5.66 |
1.24 |
0.679 |
0.50-2.55 |
5 (3.3) |
5.76 |
0.87 |
1.000 |
0.28-2.02 |
|
66-85 |
2 (1.3) |
0.14 |
13.91 |
0.019* |
1.68-50.24 |
2 (1.3) |
2.40 |
0.83 |
0.860 |
0.10-3.01 |
4 (2.6) |
3.44 |
1.16 |
0.902 |
0.32-2.98 |
1 (0.7) |
3.01 |
0.33 |
0.394 |
0.01-1.85 |
|
Younger Group (Subjects ≤50) |
3 (2.0) |
0.94 |
3.18 |
0.140 |
0.66-9.30 |
19 (12.6) |
21.9 |
0.87 |
0.633 |
0.52-1.36 |
16 (10.6) |
24.4 |
0.66 |
0.097 |
0.38-1.07 |
36 (23.8) |
26.8 |
1.34 |
0.104 |
0.94-1.86 |
|
Older Group (Subjects >50) |
4 (2.6) |
0.82 |
4.89 |
0.020* |
1.33-12.53 |
21 (13.9) |
18.3 |
1.15 |
0.587 |
0.71-1.75 |
24 (15.9) |
26.4113
|
0.91 |
0.731 |
0.58-1.35 |
28 (18.5) |
31.5 |
0.89 |
0.611 |
0.59-1.29 |
|
PWID |
5 (3.3) |
1.15 |
4.37 |
0.013* |
1.42-10.19 |
23 (15.2) |
24.5 |
0.94 |
0.864 |
0.60-1.41 |
25 (16.6) |
27.5 |
0.91 |
0.719 |
0.59-1.34 |
29 (19.2) |
28.8 |
1.01 |
1.000 |
0.67-1.45 |
|
Non-PWID |
2 (1.3) |
0.61 |
3.27 |
0.252 |
0.40-11.80 |
17 (11.3) |
15.7 |
1.09 |
0.800 |
0.63-1.74 |
15 (9.9) |
23.3 |
0.65 |
0.094 |
0.36-1.06 |
35 (23.2) |
29.5 |
1.19 |
0.353 |
0.83-1.65 |
|
Note: Standardized Prevalence Ratios were
calculated to examine differences between drug user cohort and NHIS data.
Boldface indicates statistical significance in two-tailed Fisher exact test (*
p < 0.05 and ** p < 0.01).
PWID:
Persons Who Inject Drugs; N.C.: Non-Calculable due to insufficient data; NH:
Non-Hispanic.